IL1A and neoplasm: In the lungs, lung MPs and mo-macs were also significantly reduced in number upon anakinra therapy (Fig. 4, N and O), indicating that blocking IL-1 signaling during tumor initiation deters HSC commitment to the GMP lineage and the recruitment of GMP-derived cells to the TME.